Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VASERETIC | 25MG 8MG | TABLET | Resolved | 2017-11-27 | 2017-12-21 | 30754 |
| VASERETIC | 25MG 8MG | TABLET | Resolved | 2019-02-11 | 2019-03-15 | 75352 |
| VASERETIC | 25MG 8MG | TABLET | Resolved | 2019-03-22 | 2019-04-26 | 79221 |
| VASERETIC | 8MG 25MG | TABLET | Resolved | 2020-04-24 | 2020-05-26 | 113158 |
| VASERETIC | 25MG 8MG | TABLET | Resolved | 2021-12-02 | 2022-02-01 | 150365 |
| VISKAZIDE | 25MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151232 |
| VISKAZIDE | 50MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151235 |
| ZESTORETIC | 25MG 20MG | TABLET | Resolved | 2019-12-18 | 2020-01-18 | 101520 |
| ZESTORETIC | 25MG 20MG | TABLET | Actual shortage | 2023-11-28 | 2023-12-16 | 211675 |
| ZESTORETIC | 12.5MG 10MG | TABLET | Resolved | 2023-06-19 | 2023-07-13 | 195535 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| AMI-HYDRO TAB | 50MG 5MG | TABLET | Discontinued | 2017-05-08 | 2017-05-08 | 9475 |
| APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
| APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |